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Uncoupling Sarco-endoplasmic Reticulum Ca2-ATPase
(SERCA) ATP Hydrolysis from Ca2 Transport*
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Background: Both phospholamban (PLB) and sarcolipin (SLN) regulate SERCA activity, however, only SLN uncouples
SERCA.
Results: The N and C termini of SLN, or the N terminus and transmembrane region of PLB, confer protein-specific
function.
Conclusion: SLN N terminus plays a role in dynamic interaction and uncoupling of SERCA.
Significance: SERCA uncoupling by SLN increases heat production implicating SLN-SERCA interaction in muscle
thermogenesis.
The sarcoendoplasmic reticulum Ca2-ATPase (SERCA) is
responsible for intracellular Ca2 homeostasis. SERCA activity
inmuscle can be regulated by phospholamban (PLB), an affinity
modulator, and sarcolipin (SLN), an uncoupler. Although PLB
gets dislodged fromCa2-bound SERCA, SLNcontinues to bind
SERCA throughout its kinetic cycle andpromotes uncoupling of
Ca2 transport from ATP hydrolysis. To determine the struc-
tural regions of SLN that mediate uncoupling of SERCA, we
employedmutagenesis and generated chimeras of PLBandSLN.
In this study we demonstrate that deletion of SLN N-terminal
residues 2ERSTQ leads to loss of the uncoupling function even
though the truncated peptide can target and constitutively bind
SERCA. Furthermore, molecular dynamics simulations of SLN
and SERCA interaction showed a rearrangement of SERCA res-
idues that is altered when the SLN N terminus is deleted. Inter-
estingly, transfer of the PLB cytosolic domain to the SLN trans-
membrane (TM) and luminal tail causes the chimeric protein to
lose SLN-like function. Further introduction of the PLB TM
region into this chimera resulted in conversion to full PLB-like
function. We also found that swapping PLB N and C termini
with those from SLN caused the resulting chimera to acquire
SLN-like function. Swapping the C terminus alone was not suf-
ficient for this conversion. These results suggest that domains
can be switched between SLN andPLBwithout losing the ability
to regulate SERCA activity; however, the resulting chimeras
acquire functions different from the parent molecules. Impor-
tantly, our studies highlight that the N termini of SLN and PLB
influence their respective unique functions.
The sarcoendoplasmic reticulum Ca2-ATPase (SERCA)6
pump is a P-type ATPase that catalyzes the transport of two
Ca2 ions into the lumen of the sarcoplasmic reticulum (SR),
at the expense of energy from the hydrolysis of one ATP
molecule (1). SERCA pump activity in cardiac and skeletal
muscle is regulated by the Ca2 ion gradient across the SR
and by its regulatory proteins phospholamban (PLB) and sar-
colipin (SLN), which physically interact with SERCA in a
Ca2-sensitive manner (2–5). PLB is a 52-amino acid pro-
tein, consisting of a single transmembrane (TM) 22-residue
-helix connected to a 30-residue -helical cytoplasmic
domain. The role of PLB as an important regulator of cardiac
contractility has been extensively studied (6, 7). PLB modu-
lates SERCA pump affinity for Ca2 and binds to SERCA in
the Ca2-free state (8–10). PLB phosphorylation has been
shown to relieve inhibition of SERCA and accelerate Ca2
uptake causing increased muscle relaxation (7). Compared
with PLB, SLN is a much shorter 31-amino acid protein with
a TM -helix, an unstructured 7-residue cytosolic N termi-
nus, as well as a unique C-terminal luminal tail (RSYQY) that
is highly conserved from mouse to human (2, 3, 11). Unlike
PLB, SLN is expressed abundantly in skeletal muscle tissues
but its expression in cardiac muscle is restricted to the atria,
although it is reported to be up-regulated in the hypertro-
phied and failing ventricle (12).
Initial studies on SLN suggested that SLN is an uncoupler of
the SERCA pump and could enhance heat production at the
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expense of ATP hydrolysis (13, 14). Using SLN/ and SLN
overexpression mouse models, we recently showed that SLN is
an important player in muscle thermogenesis and metabolism
(4, 15–17). Our studies revealed that mice lacking SLN were
unable tomaintain body temperature when exposed to cold but
could be rescued by re-expression of SLN. Additionally the
SLN/ mice developed obesity when fed a high fat diet sug-
gesting SLN regulation of SERCA activity contributes to whole
body energy metabolism (4). However, the mechanistic details
of how SLN binding promotes uncoupling of SERCA resulting
in heat production are unclear. Thus a major interest of our
current research is to elucidate themolecularmechanismof the
SLN-SERCA interaction.
Toward this goal we have developed a SLN and SERCA
expression system in HEK cells and employed chemical cross-
linking, SERCA ATP hydrolysis, and Ca2 uptake assays to
investigate how SLN interacts with SERCA during Ca2 trans-
port. Using this approach we recently showed that monomeric
SLN binds to SERCAdirectly and the nature of SLN interaction
with SERCA differs significantly from PLB (3, 4). A novel find-
ing of this study was that although increasing the Ca2 concen-
tration reduced the interaction between SERCA and SLN, it did
not abolish the interaction. Interestingly, SLN was also able to
bind to SERCA in theCa2-bound, phosphoenzyme conforma-
tion of the pump, E1P. In contrast, PLB binds to SERCA only in
the Ca2-free E2 state of the pump (3, 8, 10, 18). These studies
highlighted a key difference between SLN and PLB: that only
SLN can bind to SERCA during Ca2 transport and this unique
property of SLN leads to uncoupling of SERCA. Despite these
findings, the detailed mechanism of how SLN binding to
SERCApromotes uncoupling of the pump and causes release of
Ca2 back to the cytosol is yet to be understood.
To date, attention has been focused on the C-terminal tail of
SLN as the regulator of SERCA activity (19–21). Furthermore,
recent x-ray crystallographic studies on co-crystals of SERCA-
SLN and SERCA-PLB have added valuable information about
the interaction of monomeric PLB or SLN with SERCA (22–
24). However, these crystal structures were unable to identify
where the N terminus of SLN or PLB interact with SERCA, due
to the dynamic nature of the N terminus. Previous studies have
found that the N-terminal domain of PLB is critical for the
modulation of SERCA pump function (25–27). The most con-
spicuous structural differences between SLN and PLB lie in
their N- and C-terminal regions, which may dictate their func-
tional differences in SERCA regulation. Therefore, a major
objective of this study was to investigate the structural regions
of SLNnecessary for interaction and uncoupling of SERCA.We
especially investigated whether the N terminus regulates the
uncoupling function of SLN. In the present study we generated
chimeras by swapping SLNandPLBdomains to test the specific
function of each.Our studies for the first time demonstrate that
theN terminus of SLNplays an important role in its uncoupling
action on SERCA.
Experimental Procedures
Materials—Lipofectamine,DMEM, and other cell culture re-
agents were obtained from Invitrogen. The cross-linking re-
agent 1,6-bismaleimidohexane was purchased from Pierce
(Thermo Scientific). Thapsigargin, sodium orthovanadate,
AlCl3, and KOH were purchased from Sigma. 45CaCl2 was
obtained from PerkinElmer Life Sciences.
Generation of SERCA, SLN, and PLB Constructs—The SLN,
PLB, and SERCA constructs were generated by PCR amplifica-
tion and cloning into pcDNA3.1() expression vector as
reported previously (3). The rat SERCA1 cDNA sequence that
has 99% homology with mouse SERCA1 was cloned into the
pcDNA3.1() vector. Mouse SLN and PLB cDNAs were PCR
amplified and cloned into pcDNA3.1() vector. The desired
mutagenesis of rat SERCA1, mouse SLN, and mouse PLB were
done using the QuikChangeTM site-directed mutagenesis kit
(Agilent Technologies). All cDNA clones and mutated con-
structs were confirmed by direct sequencing. We have previ-
ously shown that E7C SLN and N30C PLB are similar in func-
tion to WT SLN and WT PLB (3). The mutants E7C SLN and
N30C PLB were used in this study as native SLN and PLB, and
also to generate all chimeras to enable cross-linking with
SERCA at Cys318 (hence, E7C SLN and N30C PLB will be
denoted as SLN and PLB throughout this text for simplicity, as
shown in Fig. 1, A and B). Residues 2–6 of SLN were deleted to
make the SLNNTdelmutant. The SLNN terminus (SLN residues
1–7) was replaced with the PLB N-terminal domain (PLB resi-
dues 1–30) to make Chimera-1. The last three residues (MLL)
FIGURE1.Designof SLNandPLBchimeras.A,mouse E7CSLNandN30CPLB
cDNAs were used for generation of the constructs. SLN (31 aa) is represented
as: cytosolic N terminus (black) consisting of 7 residues, TM segment (light
green) formed by residues 8–26 spanning the SRmembrane and the luminal
C terminus (dark green), which contains residues 27–31. Phospholamban (52
aa) is represented as: cytosolic N terminus (red) containing residues 1–30 and
TM (blue) containing residues 31–52. SLNNTdel construct was made by delet-
ing SLN-N-terminal residues 2–6 (ERSTQ). Chimera-1 contained PLB residues
1–30 and SLN residues 8–31. Chimera-2 had PLB residues 1–49, followed by
RSYQY, the C terminus of SLN. Chimera-3 contained SLN, N-terminal residues
1–7, residues 31–49 of the PLB TM domain, and SLN residues RSYQY at the C
terminus. B, sequence alignment of SLN, PLB, and their chimeras showing the
conserved amino acids in the transmembrane domain (red). Highlighted blue
residues were mutated to cysteine for cross-linking with Cys318 on SERCA.
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in the C-terminal of PLB were replaced with SLN C-terminal
tail residues, RSYQY to obtain Chimera-2. The length of PLB
TMwas kept intact to prevent possible mis-localization of PLB
(28), as well as to ensure ideal interaction of RSYQY with
SERCA. The N-terminal residues 1–30 of Chimera-2 were
replaced with residues 1–7 of SLN to get Chimera-3 (Fig. 1, A
and B). We further mutagenized residues 3RS to AA, 5TQ to
AA, as well as 3RSTQ to AAAA to obtain N-terminal alanine
mutants of SLN. Protein expression of the chimeras was deter-
mined using the SLN antibody, which detects the C-terminal
RSYQY sequence of SLN. PLB expression was determined by
PLB antibody, which recognizes residues 2–13 of PLBN-termi-
nal domain.
Expression of Proteins andMicrosome Preparation—HEK293
cells were co-transfected with SERCA and SLN or PLB cDNAs
at a 1:2 ratio, using Lipofectamine 2000. The cells were har-
vested in PBS 48 h post-transfection and the pellet was flash
frozen in liquid nitrogen and stored at 80 °C. Microsomes
from transfected cells were prepared as described previously
(3).
SERCA-mediatedCa2Uptake andATPHydrolysis Assays—
Oxalate-supported Ca2 uptake assay was performed to deter-
mine the effect of SLN, PLB, or their mutants on SERCA-me-
diated Ca2 transport. The proteins were expressed in HEK
cells by transfection of DNA using Lipofectamine (3). HEK
homogenates were incubated in Ca2 uptake buffer with the
desired freeCa2 level as determined byMaxchelatorwebware.
Aliquots of the reaction were collected and filtered at 30, 60,
and 90 s. The filters were washed and bound radioactive 45Ca2
wasmeasured (29). ATPhydrolysis activitywasmeasured using
the Biomol green phosphate assay reagent (3, 30). The reaction
was initiated by addition of 5 g of microsomes in the Ca2
uptake buffer and samples were collected at the end of 30 min.
The amount of Pi release was calculated as nanomole of Pi/mg/
min. Values of reactions carried out in the presence of thapsi-
gargin (TG), a SERCA inhibitor, were subtracted from all sam-
ples to obtain SERCA specific activity (3).
All ATP hydrolysis and Ca2 uptake assays were carried out
with a SERCA control for each sample. The SERCA protein
level in the samples was normalized to that in the control to
obtain the final absolute activity values. The final values were
expressed as a percentage of the maximum control SERCA
activity. Activity curves with n at least 3 measurements were
generated using sigmoidal dose-response curve fitting in the
GraphPad Prism 6 software to get the best-fit values  S.E.
Analysis of data were done using ANOVA followed by Dun-
nett’s multiple comparisons test.
Chemical Cross-linking—Chemical cross-linking of proteins
was performed using the 10-Å homo-bifunctional sulfhydryl
cross-linker, 1,6-bismaleimidohexane, as previously described
(3). Briefly, 15g of microsomes weremixed with 3mMATP in
cross-linking buffer followed by addition of 0.1 mM cross-
linker. The reaction was stopped after incubation for 1 h at
25 °C, by the addition of SDS-PAGE sample-loading buffer con-
taining 100 mM dithiothreitol. Specific cross-linking of SLN,
SLNNTdel, Chimera-1, andChimera-3 to SERCA showed a band
above 110 kDa probed with anti-SLN antibody, whereas PLB or
the Chimera-2 interaction with SERCA showed a 116-kDa
band probed with anti-PLB antibody. The effect of TG was
studied by adding 0–10MTG to the reactionmixture without
Ca2, in the presence of ATP, before the addition of cross-
linker (3).
Cross-linking to Different Kinetic States of SERCA—Stable
analogs of the major intermediates of SERCA kinetic steps (E2,
E1, E1PCa2ADP, and E2P) were obtained by incubatingmicro-
somes in a cross-linking reaction buffer for 45min at 25 °Cwith
different chemicals, before addition of 1,6-bismaleimido-
hexane (3, 31, 32). Incubating the microsomes without ATP
induced the E2 state. 100 M free Ca2 with 3 mM ATP in the
buffer resulted in a prevalence of the E1PCa2 state. Incubation
with 50 M AlCl3 and 3 mM KF and 3 mM ADP resulted in
formation of the E1AlFxADP complex, an E1PCa2ADP ana-
log. Last, the analog of the E2P to E2 transition state (E2AlF4)
was produced by addition of 50 M AlCl3 and 3 mM KF to the
buffer.
MD Simulations—The simulations were performed with the
GROMACS5.0 program (33). Formodeling the systemwe used
the crystal structure of SERCA and SLN in theMg2-bound E1
state (Protein Data Bank code 3W5A) (24). Here the ATP ana-
log TNP-AMP was deleted, whereas the bound Mg2-ion and
crystal waters were retained. For the truncated version we
deleted residues 2–6 of SLN after equilibration. We used the
same protonation scheme as Espinoza-Fonseca et al. (34),
namely that, Ca2-binding residues Glu771, Asp800, and Glu309
were kept unprotonated, whereas Glu908 was protonated. The
system consisted of SERCA, SLN, 500 POPC molecules, and
55,000 TIPS3P water molecules. The protein was inserted
into a pre-equilibrated bilayer using the “membed” option of
GROMACS 5.0 (35). Furthermore, Na and Cl ions were
added to ensure a salt concentration of 150 mM. Virtual sites
were used for all hydrogens in the system (36) allowing for a 5-fs
time step in conjunction with the CHARMM36 force field (37).
Both systemswere run for 200 ns of which 50 ns were discarded
as equilibration. Periodic boundary conditions were used, elec-
trostatic forces were calculated using the Particle Mesh Ewald
(38) method with a real space cut off of 1.2 nm, and the non-
bonded interactions were calculated using a force switch in the
range 1.0 to 1.2 nm. The temperature was kept at 310 K using
the Nose-Hoover thermostat (39, 40) with a 10-ps time con-
stant, and the pressurewas coupled semi-isotropically using the
Parrinello-Rahman barostat (41) as required by the virtual sites
method, a reference value of 1.0 bar and a time constant of 50
ps. All bonds were constrained with LINCS (42).
Results
Deletion of SLN Cytosolic Portion (N-terminal 2–6 Residues)
Leads to Loss of SLN Uncoupling Effect on SERCA—SLN has a
unique unstructured N terminus consisting of 7 aa, whereas
PLB has a 30-aa long -helical N-terminal domain. X-ray crys-
tallographic studies on SLN-SERCA co-crystals were unable to
map the location of the N terminus and the interaction of
N-terminal residues with SERCA remains a mystery so far (22,
24). We therefore wanted to determine whether the unique
N-terminal residues are responsible for the uncoupling action
of SLN on SERCA. Toward this goal, we first deleted the N-ter-
minal 2–6 residues from SLN (SLNNTdel). The deleted con-
Uncoupling of SERCA by Sarcolipin
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struct was co-expressed with SERCA in HEK cells. The mutant
protein was expressed at high levels and localized to the ER.
Microsomes containing SERCA and SLNNTdel were then cross-
linked at increasing Ca2 concentrations. As shown in Fig. 2A,
SLN interacted with SERCA at all Ca2 concentrations tested,
however, cross-linking intensity was reduced with increasing
Ca2 concentration (3, 4). SLNNTdel was also able to cross-link
with SERCA; however, the intensity of the cross-linking
remained unchanged with increasing Ca2 concentration (Fig.
2A). This data suggested that SLNNTdel lost its ability to interact
with SERCA in a Ca2-sensitivemanner but it remained bound
to SERCA constitutively.We further tested if SLNNTdel affected
SERCA activity by performing SERCA ATP hydrolysis and
Ca2 uptake assays. Our results showed that both SLN and
SLNNTdel had no significant effect on ATP hydrolysis activity
(Fig. 2B). As expected, SLN decreased the Vmax of Ca2 uptake
by 37% (Fig. 2C), which is in agreement with our previous study
(3). Interestingly SLNNTdel had no effect on SERCA Ca2
uptake (Fig. 2C). These data suggested that although SLNNTdel
was able to bind to SERCA constitutively, the deletion of the
SLNN terminusmade themolecule functionally inactive and it
no longer affected SERCA ATP hydrolysis activity or Ca2
uptake.
Replacing SLN N Terminus (1–7 aa) with PLB N-terminal
Domain (1–30 aa) Confers PLB-like Characteristics—The
above studies pointed out that deletion of the SLN N terminus
resulted in a loss of function and clearly suggested that the N
terminus is an important functional region. We then studied if
the SLN function could be restored by addition of a non-homo-
logous sequence to the N terminus. For this, we added the
FLAG tag (DYKDDDDK) onto the N terminus of SLNNTdel.
Similar to SLNNTdel, the resulting peptide was able to bind to
SERCA at all Ca2 concentrations tested but had no effect on
SERCA function (data not shown) and behaved similar to
SLNNTdel. We next wanted to determine whether adding the
PLB cytosolic domain (1–30 aa) (that has been shown to be
important for PLB regulation of SERCA) to the N-terminal-
truncated SLN would confer PLB-like function to the resulting
Chimera-1 (Fig. 1B). We therefore compared the SERCA-Chi-
mera-1 interaction with that of SERCA-SLN as well as SERCA-
PLB at increasing Ca2 concentrations. As shown in Fig. 3A,
SLN and PLB behaved as we have earlier reported (3); i.e. SLN
was able to interact with SERCA at all Ca2 concentrations
tested but PLB interaction with SERCAwas abolished at higher
Ca2 concentrations. Interestingly, Chimera-1 interacted with
SERCA up to 1 M and the cross-linking was abolished at 2 M
Ca2 (Fig. 3A), thus Chimera-1 behaved like PLB. The ATP
hydrolysis assay showed that like PLB,Chimera-1 decreased the
K0.5 of SERCA activity (K0.5 SERCA pCa 6.787 0.039; K0.5
SERCA  Chimera-1  pCa 6.638  0.014, p  0.05; K0.5
SERCA PLB pCa 6.248 0.063, p 0.0001, mean S.E.)
(Fig. 3B). The Ca2 uptake assay showed that Chimera-1 did
not inhibit the Vmax or affinity of SERCA for Ca2 (K0.5
SERCA pCa 6.745 0.02; K0.5 SERCA Chimera-1 pCa
6.535  0.134; K0.5 SERCA  PLB  pCa 6.358  0.078, p 
0.01, mean  S.E.) (Fig. 3C). These results collectively suggest
that replacing the SLN N terminus with the PLB N terminus
leads to a loss of SLN-like function in the resulting Chimera-1,
despite the fact that it has both the TMandC-terminal residues
of SLN.
SLN N Terminus Plays a Role in Uncoupling the SERCA
Pump—We additionally generated Chimeras-2 and -3 to deter-
mine the functional relevance of the SLN C and N terminus. In
Chimera-2, the C-terminal residues of PLB (MLL) were
replaced with the C-terminal residues of SLN (RSYQY). To test
the role of the SLN N terminus we created Chimera-3, using
Chimera-2 from which the N terminus of PLB was replaced
with that of SLN (MERSTQ) (although this chimera contained
the TMdomain of PLB, no PLB antibody specific for this region
is available. We therefore had to replace the C-terminal resi-
dues of PLB (MLL) with those of SLN (RSYQY) for immunode-
tection.) SLN, PLB, and the chimeras were each expressed with
SERCA in HEK cells and cross-linking and functional assays
were carried out as described above. Cross-linking studies
showed that the PLB interaction with SERCA was highly sensi-
tive to Ca2 and was abolished between 1 and 2 M Ca2. On
FIGURE2.Deletionof thecytosolicportion (residues2–6)ofSLNresults in
loss of function. A, SERCA was expressed with SLN or SLNNTdel in HEK cells.
Cross-linking was done in the presence of different concentrations of Ca2.
Representative immunoblot showsCa2-dependent cross-linkingof SLNand
SLNNTdelwith SERCA1. Protein band intensitiesweremeasured andplotted as
the percentage of band intensity of reactionwithout Ca2 (n 3–4measure-
ments) (right panel). B, SERCA ATP hydrolysis activity was measured in reac-
tions containing SERCA alone and SERCAwith SLN or SLNNTdel. The values are
given as the percentage of SERCA Vmax (n 6measurements) (left panel). K0.5
(pCa) values of SERCA affinity for Ca2 were calculated and compared with
control SERCA (right panel). C, SERCA calciumuptakewas determined in reac-
tions containing SERCA alone and SERCAwith SLN or SLNNTdel. The values are
given asmeanof percentageof SERCAVmax (n3measurements) (left panel).
K0.5 (pCa) values of SERCA affinity for Ca
2 were calculated and compared
with control SERCA (right panel). Data are mean  S.E., **  SLN Vmax is
reduced as comparedwith SERCA Vmax, ** p 0.01 as analyzed by ANOVA.
Uncoupling of SERCA by Sarcolipin
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the other hand, Chimera-2 interaction with SERCA was stron-
ger and persisted even at 2 M Ca2 but was abolished at 5 M
Ca2 (Fig. 4A), suggesting that the addition of the SLN C ter-
minus (RSYQY) residues onto PLB increased its affinity to
SERCA. Interestingly, Chimera-3 cross-linked to SERCA at all
Ca2 concentrations tested, in a Ca2-sensitive manner (Fig.
4A) as observed for SLN (Fig. 2A).
To further determine how Chimeras-2 and -3 affect SERCA
activity, wemeasured SERCAATPhydrolysis andCa2 uptake.
The ATP hydrolysis assay showed that similar to PLB, the pres-
ence of Chimera-2 decreased the affinity of the SERCA pump
for Ca2, without a significant effect on Vmax of the pump (K0.5
SERCA pCa 6.595 0.044; K0.5 SERCAChimera-2 pCa
6.378  0.05, p  0.01, mean  S.E.). The Ca2 uptake assay
also showed that Chimera-2 decreased the apparent affinity of
SERCA for Ca2 uptake, without affectingVmax (K0.5 SERCA
pCa 6.785  0.023; K0.5 SERCA  Chimera-2  pCa 6.398 
0.065, p  0.0001; mean  S.E.), suggesting that Chimera-2
retains PLB-like function. These results revealed that although
the C terminus of SLN increases the affinity of Chimera-2 to
SERCA, it functions like PLB. When we swapped the N termi-
nus of Chimera-2 with that of SLN, the resulting Chimera-3 did
not affect ATP hydrolysis activity (K0.5 SERCA pCa 6.595
0.044;K0.5 SERCAChimera-3 pCa 6.609 0.044, mean
S.E.) (Fig. 4B) and behaved similar to SLN. The Ca2 uptake
assay showed that Chimera-3 did not affect the apparent affin-
ity of SERCA for Ca2 uptake (K0.5 SERCA  pCa 6.785 
0.023;K0.5 SERCAChimera-3 pCa 6.706 0.058, mean
S.E.) but showed a 25% decrease in the Vmax of SERCA pump
(Fig. 4C). These data using Chimera-3 suggest that replacing
the PLB N terminus of Chimera-2 with that of SLN converts it
to a SLN-like molecule.
TheNTerminus of SLN Enables Its Dynamic Interaction with
SERCA—The SERCApump undergoes fourmajor kinetic steps
(E2, E1P, E2P, and E2) during Ca2 transport (1). We have
FIGURE 3. Chimera-1 containing the N terminus of PLB behaves like PLB.
A, SERCA was expressed alone or with SLN, PLB, or Chimera-1 in HEK cells.
Cross-linking was done in the presence of different concentrations of Ca2.
Representative immunoblot shows Ca2 induced alteration in cross-linking
of SLN, PLB, and Chimera-1 with SERCA. Protein band intensities were mea-
sured and plotted as the percentage of band intensity of reaction without
Ca2 (n 3–4 measurements) (right panel). B, SERCA ATP hydrolysis activity
was measured in reactions containing SERCA alone and SERCA with PLB or
Chimera-1 at various Ca2 concentrations. The values are given as percent-
age of SERCA Vmax (n  3–6 measurements) (left panel). K0.5 (pCa) values of
SERCA affinity for Ca2 were calculated and compared with control SERCA
(right panel). C, Ca2 uptake was determined in reactions containing SERCA
alone and SERCAwith PLB or Chimera-1. The values are given as the percent-
age of SERCA Vmax (n  4 measurements) (left panel). K0.5 (pCa) values of
SERCA affinity for Ca2 were calculated and compared with control SERCA
(right panel). * p 0.05; ** p 0.01; **** p 0.0001, as analyzed by
ANOVA. Data are mean S.E.
FIGURE 4. SLNN terminus plays a role in uncoupling SERCA. A, SERCAwas
expressed with PLB, Chimera-2, or Chimera-3 in HEK cells. Cross-linking was
done in the presence of different concentrations of Ca2. The representative
immunoblot shows Ca2 induced alteration in cross-linking of PLB, Chime-
ra-2, and Chimera-3with SERCA. Protein band intensities weremeasured and
plotted as the percentage of band intensity of reaction without Ca2 (n 3
measurements) (right panel). B, SERCA ATP hydrolysis activity was measured
in reactions containing SERCA and PLB, SERCAwith Chimera-2 or SERCAwith
Chimera-3 at various Ca2 concentrations. The values are given as percent-
age of SERCA Vmax (n  5 measurements) (left panel). K0.5 (pCa) values of
SERCA affinity for Ca2 were calculated and compared with control SERCA
(right panel). C, Ca2 uptake was determined in reactions containing SERCA
alone, SERCA with Chimera-2 or Chimera-3. The values are given as percent-
age of n 4 measurements (left panel). K0.5 (pCa) values of SERCA affinity for
Ca2 were calculated and compared with control SERCA (right panel). * 
Chimera-3 Vmax is reduced as compared with SERCA Vmax. * p 0.05; **
p 0.01; and **** p 0.0001 as analyzed by ANOVA. Data aremean S.E.
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previously shown that SLN interacts with SERCA through var-
ious kinetic steps of the Ca2 transport cycle, whereas PLB
cannot bind to Ca2 bound SERCA (3). Therefore we investi-
gated if SLN binding to SERCA in its various kinetic states is
dependent on the N terminus of SLN, by the use of these chi-
meras. We assessed the ability of each chimera to bind to the
five different kinetics states of SERCA as described previously
(3).Wemeasured protein cross-linking in the E2 state with and
without ATP; the Ca2 bound phospho-intermediate and tran-
sition state, as well as the E2P state. Our cross-linking results
showed that only SLN and Chimera-3 having the SLNN termi-
nus were able to interact with SERCA across all tested kinetic
states.However, PLB,Chimera-1, andChimera-2 (with the PLB
N terminus) bound only to the Ca2-free E2 conformation and
this interaction was enhanced in the presence of ATP (Fig. 5A).
It has been previously shown that PLB cannot interact with
Ca2-bound SERCA, whereas SLN can (3, 4). To further deter-
mine how Ca2 binding to both sites in SERCA affect its inter-
action with the different chimeras, we performed cross-linking
with the D351A-SERCA mutant. The D351A-SERCA mutant
can bind twoCa2 ions but cannot hydrolyze ATP; therefore in
the presence of Ca2 and ATP at pH 7.0, all the pumps remain
in a Ca2-bound state. Our results showed that SLN and Chi-
mera-3 (having SLN N terminus) were able to bind to D351A-
SERCA but Chimeras-1 and -2 dissociated from SERCA below
250 nM Ca2 (Fig. 5B). Additionally, cross-linking of SLNNTdel
and chimeras to SERCA in the presence of increasing concen-
trations of TG (inhibitor that blocks SERCA irreversibly)
showed that except for SLNNTdel, the cross-linking of all other
chimeras with SERCA was abolished at 10 M TG. This sug-
gested that the chimeras bound to active SERCApumps and the
interaction was dynamic, whereas SLNNTdel constitutively
bound to SERCA (Fig. 5C).
Alanine Mutagenesis of SLN Cytosolic Residues Alters Ca2-
dependent Interaction with SERCA—The N terminus of SLN
(MERSTQ) is relatively short and the ability of SLN to remain
bound to SERCA may involve specific interactions of the N
terminus with SERCA. To test this idea we mutated the N-ter-
minal residues to alanines and analyzed the ability of these
mutants to bind to SERCA in a Ca2-dependent manner. We
generated double alanine mutants at positions 3, 4 (3RS-AA),
and 5, 6 (5TQ-AA) at the N terminus of SLN. In addition we
mutated all 4 residues together to alanine (3RSTQ-AAAA) to
determine the effect of these residues on the function of SLN.
Our chemical cross-linking results showed that the 3RS-AA
mutant had aminimal effect on SLN cross-linking with SERCA
at a high Ca2 concentration. The 5TQ-AA mutant showed
decreased interaction with SERCA at a high Ca2 concentra-
tion, whereas mutation of all 4 residues resulted in further
reduction of the interaction, which was abolished at 2MCa2
(Fig. 6). We also performed SERCA functional assays in the
presence of these SLN mutants to study the role of the N-ter-
minal residues (Table 1). Although the Vmax values were low in
the presence of the mutant SLNs, we found no significant dif-
ference in the ATP hydrolysis activity of SERCA when
expressed with the mutants, as compared with SERCA alone.
Additionally we observed that only the 3RSTQ-AAAA SLN
mutant significantly reduced the Vmax of SERCA Ca2 uptake,
similar to native SLN. Although the SLN 3RS-AA and 5TQ-AA
lowered the Vmax of SERCA Ca2 uptake, this reduction was
not significantly different from the SERCA control or even the
SERCA SLN Vmax.
FIGURE 5. Chimeric proteins can dynamically interact with SERCA. A, SLN, PLB, and their chimeras were cross-linked with different SERCA kinetic steps
induced by chemical analogs as described previously (3). B, SLN, PLB, and their chimeraswere expressedwith D351A-SERCA, and proteinswere cross-linked at
different Ca2 concentrations. C, SLNNTdel, Chimeras-1, -2, and -3 were cross-linked with SERCA in the presence of ATP and increasing concentrations of TG.
Cross-linked proteins were immunoblotted with SLN or PLB antibody.
Uncoupling of SERCA by Sarcolipin
14062 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 22•MAY 29, 2015
 at D
EF Consortium
 - U
niv Library of Southern D
enm
ark on N
ovem
ber 6, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
The SLN N Terminus Interacts with Cytosolic Residues of
SERCA—To investigate the interactions of the N terminus of
SLN with SERCA; we performed molecular dynamics (MD)
simulations of a SERCA/POPC system with an intact SLN-
bound SERCA and with the N-terminal truncated SLN
(SLNNTdel) bound SERCA. We found several changes in
SERCA residues both at and surrounding the site of interaction
with the SLN N terminus.
The MD simulations showed a salt bridge between Arg3 of
SLN andGlu45 of SERCA. Glu45 is located on the loop connect-
ing the cytosolic domain andM1 as shown in Fig. 7A. In SERCA
 SLN, Glu45 is localized near, and is oriented toward, the N
terminus of SLN, whereas in SERCA SLNNTdel, this interac-
tion is lost and thus Glu45 fluctuates and is in general, oriented
toward the bulk. The removal of theN terminus causesGlu45 to
have different interaction patternswith residuesTrp107, Arg110,
Asn111, and Asn114 in the cytosolic region of the SERCA M2
helix in the two simulations as shown in Fig. 7B. In SERCA 
SLNNTdel all the interactions between Glu45 and SERCA resi-
dues near the N terminus of SLN are lost, consistent with the
change in spatial and orientational behavior.
The simulations also showed that residue Glu2 of SLN forms a
salt bridgewithArg324 of SERCA,which is locatedon the cytosolic
half of the M4 helix (M4C) and is oriented toward the groove in
SERCAwhere SLN is bound. This helixM4C has been previously
implicated in inter-domain communication in the SERCA Ca2
transport cycle (43, 44). Fig. 7C shows representative snapshots
from the two systems. In SERCA SLNNTdel, the loss of this salt
bridge results in changes in interactions with Asn111, Asn114, and
Ala118. For Asn114 and Ala118 the interaction becomes stronger
(distance decreases) and for Asn111 the interaction becomes
weaker when removing the N terminus as can be seen in Fig. 7D.
FIGURE6.Cytosolic residuesof SLN influence its interactionwithSERCA inaCa2-sensitivemanner.A, alaninemutationof SLNN terminus residues alters
Ca2 sensitivity of SERCA-SLN cross-linking. SERCA was co-expressed with SLN, SLN-3RS-AA, SLN-5TQ-AA, and SLN-3RSTQ-AAAA mutants in HEK cells. SERCA
and SLN or its mutants were cross-linked in the presence of different concentrations of Ca2. Cross-linked proteins were detected by immunoblotting using
SLN antibody. Representative immunoblots show Ca2 induced alteration in cross-linking of SLN and its mutants with SERCA (upper panel). Protein band
intensities were measured and plotted as the percentage of band intensity of reaction without Ca2 (n  3 measurements) (lower panel). B, SERCA ATP
hydrolysis activity was measured in reactions containing SERCA alone, and SERCAwith SLN alaninemutants SLN-3RS-AA, SLN-5TQ-AA, and SLN-3RSTQ-AAAA,
each at various Ca2 concentrations. The values are given as percentage of SERCA Vmax (n 5 measurements). C, Ca
2 uptake was determined in reactions
containing SERCA alone, and SERCA with SLN Alanine mutants SLN-3RS-AA, SLN-5TQ-AA, and SLN-3RSTQ-AAAA each. The values are given as percentage of
SERCA Vmax (n 4 measurements).
TABLE 1
The effect of SLN N-terminal alanine mutants on SERCA ATP hydrolysis activity and calcium uptake
The K0.5 values are in pCa units. The Vmax values are expressed as a percentage of control SERCA Vmax. Results are mean S.E. for n 3 measurements.
ATP hydrolysis activity Calcium uptake
K0.5 Vmax K0.5 Vmax
SERCA 6.52 0.06 97.97 1.18 6.67 0.05 95.84 3.13
SERCA SLN 6.57 0.13 97.18 11.27 6.80 0.06 65.27 4.69a
SERCA SLN 3RS-AA 6.61 0.04 87.47 8.03 6.56 0.08 75.68 5.47
SERCA SLN 5TQ-AA 6.61 0.06 84.86 6.83 6.68 0.05 72.58 2.14
SERCA SLN 3RSTQ-AAAA 6.40 0.04 80.46 5.00 6.57 0.05 63.01 9.99a
a p 0.05, as compared to control SERCA values, analyzed by ANOVA.
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Discussion
A major objective of this study was to determine the struc-
tural regions that enable SLN interaction with SERCA and pro-
mote uncoupling of the pump from Ca2 transport. We
recently showed that monomeric SLN binds to the TM groove
on SERCA consisting of TMs M2, M6, and M9, a region previ-
ously characterized to bindPLB (45). The binding of SLN to this
groove, however, involves a different set of SERCA residues (3,
45). Most importantly, we showed that SLN remains bound to
SERCA in the presence of high Ca2, whereas PLB is displaced
from the groove. We also showed that SLN interacts with
SERCA throughout the Ca2 transport cycle and proposed that
its ability to interact with SERCA during the Ca2 transport
cycle promotes uncoupling of the SERCA pump. These and
other published studies suggest that PLB is an affinity modula-
tor of SERCA (inhibits SERCA at submaximal Ca2 concentra-
tions), whereas SLN is an uncoupler of the pump and decreases
Vmax of Ca2 uptake (3, 7, 10, 13, 46, 47). It is, however, unclear
how SLN is able to uncouple the SERCA pump.
To date, the structural components that enable SLN to
uncouple SERCA remain to be characterized. SLN is a short
31-amino acid protein consisting of an unstructured 7-residue
(MERSTQE) N terminus, a TM -helix made of 19 residues,
and a unique 5-residue (RSYQY) C-terminal luminal tail (48–
51). Previous functional studies on SLN suggested that the
C-terminal RSYQY sequence is important for SERCA regula-
tion (19–21). The published x-ray crystallographic studies by
Toyoshima et al. andWinther, Bublitz, and co-workers (22, 24)
are an important milestone, which has shown that SLN indeed
binds to the M2, M6, and M9 TM groove and stabilizes the E1
state of SERCA. The crystal structures showed interaction in
the TM region but were unable to identify the N terminus loca-
tions of SLN on SERCA; therefore the nature of the SLN N
terminus interaction with SERCA and its role in regulating
SERCA function have remained elusive.We knew that SLN and
PLB bind to the same SERCA groove but produce different
functional outcomes (3, 13–14, 45). Hence, we chose to gener-
ate chimeras between PLB and SLN to dissect their unique
functional domains and determine if the domains could be
exchanged without losing function. Results from our study
show that we were successful in creating functional chimeras.
Moreover, these chimeras inherited the function of their
respective N terminus.
The TM and C Terminus Are Sufficient for SLN Localization
and Interaction with SERCA—Despite recent progress in local-
izing SLN to the SERCA TM groove, it remained unclear if the
uncoupling function could be localized to a particular portion
or a set of residues in SLN. In the present study, we focused our
FIGURE 7. MD Simulations of SERCA interaction with native SLN and SLNNTdel mutant. A and C, snapshot from SERCA  SLN and SERCA  SLNNTdel
superimposed. The transparent structure is from the latter system. SLN and SLNNTdel are colored orange.A, the residues shown are Glu45 on SERCA andArg3 on
SLN. B, radial distribution functions between SERCAGlu45 and Trp107, Arg110, Asn111, andAsn114. The solid lines are for SERCA SLN and the dashed lines are for
SERCA SLNNTdel.C, the residue shown is Arg324 on SERCA.D, radial distribution functions between SERCAArg324 andAsn111, Asn114, andAla118. The solid lines
are for SERCA SLN and the dashed lines are for SERCA SLNNTdel.
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attention on investigating the role of the SLNN terminus in the
uncoupling of SERCA. We found that deletion of the N termi-
nus (ERSTQ) of SLN disabled its function (Fig. 2). The mutant
peptide (SLNNTdel) constitutively bound to SERCA, failed to
showCa2 sensitivity, and had no effect on SERCACa2 trans-
port. We have earlier shown that native SLN or PLB are dis-
placed from SERCA by TG, a SERCA inhibitor, which locks the
pump irreversibly in the E2 conformation (3). Interestingly, the
SLNNTdel peptide could not be dislodged from SERCA in the
presence of TG (Fig. 5C). Thus SLN without its N terminus
remained in the TM groove and lost its ability to dynamically
interactwith SERCA.These studies suggest that the occupation
of the SERCA groove by the truncated SLN peptide is not suf-
ficient to cause uncoupling. At the same time thismutant could
successfully localize to SERCA,which suggests that theTMand
C terminus are vital for SLN localization and interaction with
SERCA in the TM groove (21), which is also in agreement with
recent x-ray crystallographic studies (22, 24).
TheNTermini of SLNandPLBAre Essential for TheirUnique
Function—Because the truncated SLN peptide failed to show
any effect on SERCA Ca2 transport, we added a heterologous
N-terminal FLAG tag and also the N-terminal domain (1–30
aa) of PLB (Chimera-1) to observe an effect on SERCA.Only the
addition of the PLB N terminus showed an effect on SERCA
function and caused Chimera-1 to decrease the apparent affin-
ity of SERCA but not Vmax (Fig. 3). This is in agreement with
previous findings showing that the inhibitory function of PLB
can be localized to the N terminus (25, 26, 52).
Similarly, the PLB N terminus, not the SLN C terminus,
determined the function of Chimera-2. Although the SLN C
terminus increased the binding affinity of Chimera-2 to
SERCA, which is in agreement with recent studies by Gorski et
al. (20), we, however, found that it was unable to promote
SERCA uncoupling in the presence of the PLB N-terminal
domain (Fig. 4). An interesting observationwas that Chimera-2
behaved more like PLB than Chimera-1. The only variable fac-
tor between these two chimeras is the TM segment, which sug-
gests that the TMof PLB plays a significant role in defining PLB
characteristics. We additionally investigated if the swapping of
the PLB N terminus of Chimera-2 with the SLN N terminus
would promote SERCA uncoupling. The resulting Chimera-3
behaved much like SLN, with no effect on the apparent affinity
of SERCA but a decreased Vmax of Ca2 uptake (Fig. 4).
Although a direct comparison between SLN and Chimera-3
was notmade, Chimera-3 also highlighted that the TMdomain
can be switched easily without affecting SLN properties. These
studies employing chimeras allowed us to conclude that the N
termini of SLN and PLB influence their respective identity as an
uncoupler or affinity modulator. However, the TM and C ter-
minus are important for SLN localization within the SERCA
groove and without them SLN will not be able to interact with
SERCA. In this study we additionally show that the TMs of PLB
and SLN could be switched without compromising SLN
function.
Although the above studies identified the SLNN terminus as
an important uncoupling portion, it remained unclear how this
region interacts with SERCA in a Ca2-sensitive manner.
Therefore we mutagenized the N-terminal RSTQ residues into
alanines and found that mutagenesis from 2 to 4 residues
increasingly weakened the mutants’ ability to bind to SERCA
(Fig. 6) as compared with native SLN. This could be a result of
unfavorable interaction between SERCA residues and the
N-terminal alanines on SLN, causing a change in the orienta-
tion of the SLN TM and C terminus within the SERCA binding
groove. On the other hand, compared with alanine mutagene-
sis, deletion of the N terminus caused the truncated SLN pep-
tide to constitutively bind to SERCA even at a high 5 M Ca2
concentration and unlike native SLN, it lost its SERCA regulat-
ing function and remained bound in the presence of TG. The
SLN N terminus is thus important for its binding and dynamic
interaction with SERCA during the kinetic cycle of the pump.
The N-terminal alanine mutations, however, did not signifi-
cantly alter the functional effect of SLN on SERCA (Table 1). It
should be noted that thesemutagenesis studies are only prelim-
inary and further investigation with exhaustive mutagenesis
using a range of amino acids is necessary to provide a definitive
picture of how the side chain interactions in this region affect
SLN function.
Evolution and Functional Divergence of SLN and PLB—Our
studies using native SLN, PLB, and their chimeras, show that
domain function can be separated and the domains can func-
tion independently of each other. The very fact that they both
bind to the same SERCA groove, and that the two proteins have
retained considerable homology in theTMregion, provide sup-
port to their common origin. Recent studies inDrosophila have
identified an ancestral protein, Sarcolamban, as a regulator of
SERCA, which shares most homology in the TM region with
PLB and SLN. This finding and studies on the SLN and PLB
structure suggest that these proteins must have evolved from a
common ancestral gene involved in Ca2 homeostasis (53).
However, somewhere during evolution, the ancestral gene
duplicated and diverged to code for PLB and SLN with very
distinct functions even before the dawn of vertebrates (53, 54).
Thus PLB and SLN represent a unique set of proteins that bind
to and interact with the same SERCA pump but have entirely
different functional outcomes.
Mechanism of SLN Uncoupling of SERCA—Although the
mechanism of SLN uncoupling remains to be understood, our
study represents an important first step toward this goal. Dur-
ing Ca2 transport, the SERCApump transports twoCa2 ions
per molecule of ATP hydrolyzed (1, 55, 56). However, when
SLN is bound to SERCA, the energy from ATP hydrolysis does
not lead to accumulation of Ca2 in the SR (3, 4), but is released
as heat, thus contributing to thermogenesis in muscle (3, 4).
Crystallography data of the various SERCA kinetic states show
that transferring Ca2 to the SR lumen requires rotation of the
A domain of SERCA, which results in the sliding of TM helices
that releases Ca2 ions into the SR lumen (1, 57–59). We pro-
pose that the interaction of SLN within the SERCA TM groove
during Ca2 transport may interfere with TM sliding, resulting
in slippage of Ca2 back into the cytosol (60). The MD simula-
tions suggest the possibility that the short and flexible N termi-
nus of SLN is capable of interacting with residues in the SERCA
cytosolic domain. Deletion of the SLNN terminus affected spa-
tial orientations of several SERCA residues, which are known to
have an influence on SERCA function. Previous studies have
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shown thatmutationsN111A andN114A lead to a reduction in
the transport of Ca2 (61), R324A has the same effect and also
inhibits the E1P-E2P transition of SERCA (the step at which
Ca2 is internalized into the SR lumen) (43, 44). Furthermore,
SERCA Glu45 lies near the cytosolic portion of the Ca2 ion
binding pathway in SERCA. Although the alanine mutagenesis
results for the role of SLN residue Arg3 are inconclusive, its
interaction with SERCA Glu45 may play a role in SLN-induced
Ca2 slippage from the pump.
In summary, for the first time we report that the cytosolic N
terminus in SLNplays an important role in uncoupling SERCA.
TheN terminus of SLNmay be responsible for ideal positioning
of the SLNTM and C terminus in the SERCA groove, to enable
uncoupling of the pump. We also show that localization to the
SRmembrane and interaction in the SERCAgroove depends on
the SLNTMandC terminus.Our studies highlight themodular
nature of the domains in SLN and PLB, which can be inter-
changed without losing their individual function. Furthermore,
we show that when exchanged, the N terminus confers identity
to the new protein. We have only begun to understand the role
of this region in SLN. Future studies should be aimed at under-
standing in further detail the interaction of the N-terminal res-
idues of SLN with SERCA.
Acknowledgment—We thank the Nordic High Performance Comput-
ing, NHPC, for providing computing hours on the Gardar
supercomputer.
References
1. Toyoshima, C., and Inesi, G. (2004) Structural basis of ion pumping by
Ca2-ATPase of the sarcoplasmic reticulum. Annu. Rev. Biochem. 73,
269–292
2. Bhupathy, P., Babu, G. J., and Periasamy, M. (2007) Sarcolipin and phos-
pholamban as regulators of cardiac sarcoplasmic reticulumCa2-ATPase.
J. Mol. Cell Cardiol. 42, 903–911
3. Sahoo, S. K., Shaikh, S. A., Sopariwala, D. H., Bal, N. C., and Periasamy,M.
(2013) Sarcolipin protein interaction with sarco(endo)plasmic reticulum
Ca2-ATPase (SERCA) is distinct from phospholamban protein, and only
sarcolipin can promote uncoupling of the SERCA pump. J. Biol. Chem.
288, 6881–6889
4. Bal, N. C., Maurya, S. K., Sopariwala, D. H., Sahoo, S. K., Gupta, S. C.,
Shaikh, S. A., Pant,M., Rowland, L. A., Bombardier, E., Goonasekera, S. A.,
Tupling, A. R., Molkentin, J. D., and Periasamy, M. (2012) Sarcolipin is a
newly identified regulator of muscle-based thermogenesis in mammals.
Nat. Med. 18, 1575–1579
5. MacLennan, D. H., and Kranias, E. G. (2003) Phospholamban: a crucial
regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol. 4, 566–577
6. Kiss, E., Ball, N. A., Kranias, E. G., and Walsh, R. A. (1995) Differential
changes in cardiac phospholamban and sarcoplasmic reticular Ca2-AT-
Pase protein levels: effects on Ca2 transport and mechanics in compen-
sated pressure-overload hypertrophy and congestive heart failure. Circ.
Res. 77, 759–764
7. Luo, W., Grupp, I. L., Harrer, J., Ponniah, S., Grupp, G., Duffy, J. J., Doet-
schman, T., and Kranias, E. G. (1994) Targeted ablation of the phospho-
lamban gene is associated with markedly enhanced myocardial contrac-
tility and loss of -agonist stimulation. Circ. Res. 75, 401–409
8. Chen, Z., Akin, B. L., and Jones, L. R. (2010) Ca2 binding to site I of the
cardiac Ca2 pump is sufficient to dissociate phospholamban. J. Biol.
Chem. 285, 3253–3260
9. Chen, Z., Akin, B. L., and Jones, L. R. (2007) Mechanism of reversal of
phospholamban inhibition of the cardiac Ca2-ATPase by protein kinase
A and by anti-phospholamban monoclonal antibody 2D12. J. Biol. Chem.
282, 20968–20976
10. Jones, L. R., Cornea, R. L., and Chen, Z. (2002) Close proximity between
residue 30 of phospholamban and cysteine 318 of the cardiac Ca2 pump
revealed by intermolecular thiol cross-linking. J. Biol. Chem. 277,
28319–28329
11. Babu, G. J., Bhupathy, P., Carnes, C. A., Billman, G. E., and Periasamy, M.
(2007) Differential expression of sarcolipin protein during muscle devel-
opment and cardiac pathophysiology. J. Mol. Cell Cardiol. 43, 215–222
12. Zheng, J., Yancey, D. M., Ahmed, M. I., Wei, C. C., Powell, P. C., Shan-
mugam, M., Gupta, H., Lloyd, S. G., McGiffin, D. C., Schiros, C. G., Den-
ney, T. S., Jr., Babu, G. J., and Dell’Italia, L. J. (2014) Increased sarcolipin
expression and adrenergic drive in humans with preserved left ventricular
ejection fraction and chronic isolated mitral regurgitation. Circ. Heart
Fail. 7, 194–202
13. Mall, S., Broadbridge, R., Harrison, S. L., Gore, M. G., Lee, A. G., and East,
J. M. (2006) The presence of sarcolipin results in increased heat produc-
tion by Ca2-ATPase. J. Biol. Chem. 281, 36597–36602
14. Smith, W. S., Broadbridge, R., East, J. M., and Lee, A. G. (2002) Sarcolipin
uncouples hydrolysis of ATP from accumulation of Ca2 by the Ca2-
ATPase of skeletal-muscle sarcoplasmic reticulum. Biochem. J. 361,
277–286
15. Sopariwala, D. H., Pant, M., Shaikh, S. A., Goonasekera, S. A., Molkentin,
J. D., Weisleder, N., Ma, J., Pan, Z., and Periasamy, M. (2015) Sarcolipin
overexpression improves muscle energetics and reduces fatigue. J. Appl.
Physiol. 118, 1050–1058
16. Maurya, S. K., Bal, N. C., Sopariwala, D. H., Pant, M., Rowland, L. A.,
Shaikh, S. A., and Periasamy, M. (2015) Sarcolipin is a key determinant of
basal metabolic rate and its oversexpression enhances energy expenditure
and resistance against diet-induced obesity. J. Biol. Chem. 290,
10840–10849
17. Rowland, L. A., Bal, N. C., Kozak, L. P., and Periasamy, M. (2015) Uncou-
pling protein 1 and sarcolipin are required to maintain optimal thermo-
genesis and loss of both systems comprimises survival of mice under cold
stress. J. Biol. Chem. 290, 12282–12289
18. Chen, Z., Stokes, D. L., and Jones, L. R. (2005) Role of leucine 31 of phos-
pholamban in structural and functional interactions with the Ca2 pump
of cardiac sarcoplasmic reticulum. J. Biol. Chem. 280, 10530–10539
19. Hughes, E., Clayton, J. C., Kitmitto, A., Esmann, M., andMiddleton, D. A.
(2007) Solid-state NMR and functional measurements indicate that the
conserved tyrosine residues of sarcolipin are involved directly in the inhi-
bition of SERCA1. J. Biol. Chem. 282, 26603–26613
20. Gorski, P. A., Glaves, J. P., Vangheluwe, P., and Young, H. S. (2013) Sarco-
(endo)plasmic reticulum calcium ATPase (SERCA) inhibition by sarcoli-
pin is encoded in its luminal tail. J. Biol. Chem. 288, 8456–8467
21. Gramolini, A. O., Kislinger, T., Asahi, M., Li, W., Emili, A., and MacLen-
nan, D. H. (2004) Sarcolipin retention in the endoplasmic reticulum de-
pends on its C-terminal RSYQY sequence and its interaction with sarco-
(endo)plasmic Ca2-ATPases. Proc. Natl. Acad. Sci. U.S.A. 101,
16807–16812
22. Winther, A. M., Bublitz, M., Karlsen, J. L., Møller, J. V., Hansen, J. B.,
Nissen, P., and Buch-Pedersen,M. J. (2013) The sarcolipin-bound calcium
pump stabilizes calcium sites exposed to the cytoplasm. Nature 495,
265–269
23. Akin, B. L., Hurley, T. D., Chen, Z., and Jones, L. R. (2013) The structural
basis for phospholamban inhibition of the calcium pump in sarcoplasmic
reticulum. J. Biol. Chem. 288, 30181–30191
24. Toyoshima, C., Iwasawa, S., Ogawa, H., Hirata, A., Tsueda, J., and Inesi, G.
(2013) Crystal structures of the calciumpump and sarcolipin in theMg2-
bound E1 state. Nature 495, 260–264
25. Toyofuku, T., Kurzydlowski, K., Tada, M., and MacLennan, D. H. (1994)
Amino acidsGlu-2 to Ile-18 in the cytoplasmic domain of phospholamban
are essential for functional association with the Ca2-ATPase of sarco-
plasmic reticulum. J. Biol. Chem. 269, 3088–3094
26. Toyofuku, T., Kurzydlowski, K., Tada, M., and MacLennan, D. H. (1994)
Amino acids Lys-Asp-Asp-Lys-Pro-Val402 in the Ca2-ATPase of cardiac
sarcoplasmic reticulum are critical for functional association with phos-
pholamban. J. Biol. Chem. 269, 22929–22932
27. Toyofuku, T., Kurzydlowski, K., Tada, M., and MacLennan, D. H. (1993)
Uncoupling of SERCA by Sarcolipin
14066 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 22•MAY 29, 2015
 at D
EF Consortium
 - U
niv Library of Southern D
enm
ark on N
ovem
ber 6, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Identification of regions in the Ca2-ATPase of sarcoplasmic reticulum
that affect functional association with phospholamban. J. Biol. Chem. 268,
2809–2815
28. Butler, J., Lee, A. G., Wilson, D. I., Spalluto, C., Hanley, N. A., and East,
J. M. (2007) Phospholamban and sarcolipin are maintained in the endo-
plasmic reticulum by retrieval from the ER-Golgi intermediate compart-
ment. Cardiovasc. Res. 74, 114–123
29. Ji, Y., Loukianov, E., and Periasamy, M. (1999) Analysis of sarcoplasmic
reticulum Ca2 transport and Ca2 ATPase enzymatic properties using
mouse cardiac tissue homogenates. Anal. Biochem. 269, 236–244
30. Andersen, J. P. (1995) Functional consequences of alterations to amino
acids at theM5S5 boundary of the Ca-ATPase of sarcoplasmic reticulum.
J. Biol. Chem. 270, 908–914
31. Daiho, T., Yamasaki, K., Danko, S., and Suzuki, H. (2007) Critical role of
Glu40-Ser48 loop linking actuator domain and first transmembrane helix
of Ca2-ATPase in Ca2 deocclusion and release from ADP-insensitive
phosphoenzyme. J. Biol. Chem. 282, 34429–34447
32. Inesi, G., Lewis, D., Toyoshima, C., Hirata, A., and de Meis, L. (2008)
Conformational fluctuations of the Ca2-ATPase in the nativemembrane
environment: effects of pH, temperature, catalytic substrates, and thapsi-
gargin. J. Biol. Chem. 283, 1189–1196
33. Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., and
Berendsen, H. J. (2005) GROMACS: fast, flexible, and free. J. Comput.
Chem. 26, 1701–1718
34. Espinoza-Fonseca, L. M., Autry, J. M., and Thomas, D. D. (2014) Micro-
second molecular dynamics simulations of Mg2- and K-bound E1 in-
termediate states of the calcium pump. PLoS One 9, e95979
35. Wolf, M. G., Hoefling, M., Aponte-Santamaría, C., Grubmüller, H., and
Groenhof, G. (2010) g_membed: Efficient insertion of a membrane pro-
tein into an equilibrated lipid bilayer with minimal perturbation. J. Com-
put. Chem. 31, 2169–2174
36. Loubet, B., Kopec, W., and Khandelia, H. (2014) Accelerating all-atom
MD simulations of lipids using amodified virtual-sites technique. J. Chem.
Theory Comput. 10, 5690–5695
37. Klauda, J. B., Venable, R. M., Freites, J. A., O’Connor, J. W., Tobias, D. J.,
Mondragon-Ramirez, C., Vorobyov, I., MacKerell, A. D., Jr., and Pastor,
R. W. (2010) Update of the CHARMM all-atom additive force field for
lipids: validation on six lipid types. J. Phys. Chem. B 114, 7830–7843
38. Darden, T., York, D., and Pedersen, L. (1993) Particle mesh Ewald: an N
log (N) method for Ewald sums in large systems. J. Chem. Phys. 98,
10089–10092
39. Nosé, S. (1984) A molecular dynamics method for simulations in the ca-
nonical ensemble.Mol. Phys. 52, 255–268
40. Hoover, W. G. (1985) Canonical dynamics: equilibrium phase-space dis-
tributions. Phys. Rev. A 31, 1695–1697
41. Parrinello, M., and Rahman, A. (1981) Polymorphic transitions in single
crystals: a new molecular dynamics method. J. Appl. Phys. 52, 7182–7190
42. Hess, B., Bekker, H., Berendsen, H. J., and Fraaije, J. G. (1997) LINCS: a
linear constraint solver for molecular simulations. J. Comput. Chem. 18,
1463–1472
43. Yamasaki, K., Daiho, T., Danko, S., and Suzuki, H. (2004) Multiple and
distinct effects of mutations of Tyr122, Glu123, Arg324, and Arg334 involved
in interactions between the top part of second and fourth transmembrane
helices in sarcoplasmic reticulum Ca2-ATPase: changes in cytoplasmic
domain organization during isometric transition of phosphoenzyme in-
termediate and subsequent Ca2 release. J. Biol. Chem. 279, 2202–2210
44. Takahashi, M., Kondou, Y., and Toyoshima, C. (2007) Interdomain com-
munication in calcium pump as revealed in the crystal structures with
transmembrane inhibitors. Proc. Natl. Acad. Sci. U.S.A. 104, 5800–5805
45. Asahi, M., Sugita, Y., Kurzydlowski, K., De Leon, S., Tada, M., Toyoshima,
C., andMacLennan, D. H. (2003) Sarcolipin regulates sarco(endo)plasmic
reticulum Ca2-ATPase (SERCA) by binding to transmembrane helices
alone or in association with phospholamban. Proc. Natl. Acad. Sci. U.S.A.
100, 5040–5045
46. Brittsan, A. G, Carr, A. N., Schmidt, A. G., and Kranias, E. G. (2000)
Maximal inhibitin of SERCA2 Ca2 affinity by phospholamban in trans-
genic hearts overexpressing a non-phosphorylatable for of phospholam-
ban. J. Biol. Chem. 275, 12129–12135
47. Chu, G., Lester, J. W., Young, K. B., Luo, W., Zhai, J., and Kranias, E. G.
(2000) A single site (Ser-16) phosphorylation in phospholamban is suffi-
cient in mediating its maximal cardiac responses to -agonists. J. Biol.
Chem. 275, 38938–38943
48. Odermatt, A., Becker, S., Khanna, V. K., Kurzydlowski, K., Leisner, E.,
Pette, D., andMacLennan, D. H. (1998) Sarcolipin regulates the activity of
SERCA1, the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2-
ATPase. J. Biol. Chem. 273, 12360–12369
49. Mascioni, A., Karim, C., Barany, G., Thomas, D. D., and Veglia, G. (2002)
Structure and orientation of sarcolipin in lipid environments. Biochemis-
try 41, 475–482
50. Hellstern, S., Pegoraro, S., Karim, C. B., Lustig, A., Thomas, D. D., Mo-
roder, L., and Engel, J. (2001) Sarcolipin, the shorter homologue of phos-
pholamban, forms oligomeric structures in detergentmicelles and in lipo-
somes. J. Biol. Chem. 276, 30845–30852
51. Traaseth, N. J., Ha, K. N., Verardi, R., Shi, L., Buffy, J. J., Masterson, L. R.,
andVeglia, G. (2008) Structural and dynamic basis of phospholamban and
sarcolipin inhibition of Ca2-ATPase. Biochemistry 47, 3–13
52. Reddy, L. G., Autry, J. M., Jones, L. R., and Thomas, D. D. (1999) Co-
reconstitution of phospholamban mutants with the Ca-ATPase reveals
dependence of inhibitory function on phospholamban structure. J. Biol.
Chem. 274, 7649–7655
53. Magny, E. G., Pueyo, J. I., Pearl, F.M., Cespedes,M. A., Niven, J. E., Bishop,
S. A., and Couso, J. P. (2013) Conserved regulation of cardiac calcium
uptake by peptides encoded in small open reading frames. Science 341,
1116–1120
54. Odermatt, A., Taschner, P. E., Scherer, S. W., Beatty, B., Khanna, V. K.,
Cornblath, D. R., Chaudhry, V., Yee, W. C., Schrank, B., Karpati, G.,
Breuning, M. H., Knoers, N., and MacLennan, D. H. (1997) Characteriza-
tion of the gene encoding human sarcolipin (SLN), a proteolipid associ-
ated with SERCA1: absence of structural mutations in five patients with
Brody disease. Genomics 45, 541–553
55. deMeis, L. (2001) Uncoupled ATPase activity and heat production by the
sarcoplasmic reticulum Ca2-ATPase. J. Biol. Chem. 276, 25078–25087
56. deMeis, L. (2002) Ca2-ATPases (SERCA): energy transduction and heat
production in transport ATPases. J. Membr. Biol. 188, 1–9
57. Toyoshima, C., Nomura, H., and Tsuda, T. (2004) Lumenal gating mech-
anism revealed in calcium pump crystal structures with phosphate ana-
logues. Nature 432, 361–368
58. Toyoshima, C., and Nomura, H. (2002) Structural changes in the calcium
pump accompanying the dissociation of calcium. Nature 418, 605–611
59. Toyoshima, C., Nakasako, M., Nomura, H., and Ogawa, H. (2000) Crystal
structure of the calcium pump of sarcoplasmic reticulum at 2.6-Å resolu-
tion. Nature 405, 647–655
60. Daiho, T., Yamasaki, K., Danko, S., and Suzuki, H. (2014) Second trans-
membrane helix (M2) and long range coupling in Ca2-ATPase. J. Biol.
Chem. 289, 31241–31252
61. Clarke, D. M., Maruyama, K., Loo, T. W., Leberer, E., Inesi, G., and Ma-
cLennan, D. H. (1989) Functional consequences of glutamate, aspartate,
glutamine, and asparagine mutations in the stalk sector of the Ca2-AT-
Pase of sarcoplasmic reticulum. J. Biol. Chem. 264, 11246–11251
Uncoupling of SERCA by Sarcolipin
MAY 29, 2015•VOLUME 290•NUMBER 22 JOURNAL OF BIOLOGICAL CHEMISTRY 14067
 at D
EF Consortium
 - U
niv Library of Southern D
enm
ark on N
ovem
ber 6, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Skjøth Bruhn, Wojciech Kopec, Himanshu Khandelia and Muthu Periasamy
Sanjaya K. Sahoo, Sana A. Shaikh, Danesh H. Sopariwala, Naresh C. Bal, Dennis
 Transport2+
-ATPase (SERCA) ATP Hydrolysis from Ca2+Sarco-endoplasmic Reticulum Ca
The N Terminus of Sarcolipin Plays an Important Role in Uncoupling
doi: 10.1074/jbc.M115.636738 originally published online April 16, 2015
2015, 290:14057-14067.J. Biol. Chem. 
  
 10.1074/jbc.M115.636738Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/290/22/14057.full.html#ref-list-1
This article cites 61 references, 35 of which can be accessed free at  at D
EF Consortium
 - U
niv Library of Southern D
enm
ark on N
ovem
ber 6, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
